Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 280 No 7486 p83-84
26 January 2008

This article
Reprint   Photocopy

PDF 60K, Acrobat Reader

Letters

• Statutory Committee
• EHC
• The profession
• WCPPE
• CPD
• Premises fee
• Retention fees (2)


Letters to the Editor

Retention fees

Retention fees 2008

Cost of restoration to Register (Mr U. A. Patel)

Reply from Jeremy Holmes, Chief Executive and Registrar at the Royal Pharmaceutical Society

Initiatives to assist the lower paid (Mr E. S. Maule)

Reply from Andrew Gush, Treasurer of the Royal Pharmaceutical Society, responds

Cost of restoration to Register

From Mr U. A. Patel, MRPharmS

In his reply regarding retention fees (PJ, 15 December 2007, p680), Jeremy Holmes, Chief Executive and Registrar of the Royal Pharmaceutical Society, mentions a figure of £753 as the cost of restoration to the Register of Pharmacists.

A pharmacist is paid about £23 per hour and if say another £23 is added to cover “head office costs”, ie, rent, rates, heating, pension, etc, this comes to a total of £46 per hour. The cost of restoration equates to 16 hours of work. Does the Society expect us to believe that it takes that long to restore a name?

Can we please have a breakdown of what amounts to this figure? It is not surprising that pharmacists are disillusioned by the finances of the Society.

U. A. Patel
Northwood, Middlesex

 

JEREMY HOLMES, Chief Executive and Registrar at the Royal Pharmaceutical Society, responds:

The £753 fee for restoration to the Register of Pharmacists applies where an individual who does not pay the relevant retention fee as and when required is, as a result, removed from the Register by the Society and subsequently wishes to restore his name to the Register.

It takes account of the increased administration costs involved where the Society has been obliged to pursue registrants who have failed to make retention fee payments, the costs in issuing a final demand for payment and the subsequent Society process for removal from the Register.

In considering the proposition in this letter, readers may also wish to note that pharmacists can voluntarily retire from the Register as part of the retention fee exercise. If this option is exercised the cost of being restored to the Register is £191.


Initiatives to assist the lower paid

From Mr E. S. Maule, MRPharmS

I read with interest the news item regarding General Medical Council’s announcement that its retention fees will rise this year (PJ, 15 December 2007, p668).

Its fees have risen for the first time in six years (in contrast to the annual fee increases of the Royal Pharmaceutical Society) and doctors on low incomes are entitled to a 50 per cent fee reduction.

I wonder if Andrew Gush, the Society’s Treasurer, has considered similar initiatives to aid the lower paid NHS and part-time pharmacists to cope with this years fee increase?

Ewan Maule
North Sheilds, Tyne and Wear

 

ANDREW GUSH, Treasurer of the Royal Pharmaceutical Society, responds:

I welcome this letter because helping low income members is a priority for me, but as Treasurer I must establish that the majority of members share my view before this help can be put in place.

The General Medical Council has just announced its intention to raise its fees to £390. The fee was raised by £100 from the previous level of £290. The Society’s 2008 fees increased by £108, from £287 to £395. The GMC offers a 50 per cent discount on its annual fee for those whose incomes in the relevant year would fall below £21,391.

As a result of the consultation on the proposed fees for 2008, it was clear that a low-income fee was a concession that some members desired. The Society will therefore be consulting with members on such a concession during 2008 with a view to its possible introduction in 2009.

It must, however, be borne in mind that any concession given to those on low income will imply a subsidy by those paying the full fee. The acceptability of such a subsidy will, of course, form part of that consultation.

Members are invited to make their views known by replying to this forthcoming consultation.

Send your letter to The Editor

Previous Topic (Premises fee)

Back to Top


©The Pharmaceutical Journal